Drug Type Small molecule drug |
Synonyms GDC 0349, GDC0349, RG-7603 |
Target |
Mechanism mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H32N6O3 |
InChIKeyRGJOJUGRHPQXGF-INIZCTEOSA-N |
CAS Registry1207360-89-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Phase 2 | - | - | |
Solid tumor | Phase 1 | US | 01 Jun 2011 | |
Solid tumor | Phase 1 | CA | 01 Jun 2011 |